These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12640256)
1. Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats. Toblli JE; DeRosa G; Rivas C; Cao G; Piorno P; Pagano P; Forcada P J Hypertens; 2003 Mar; 21(3):611-20. PubMed ID: 12640256 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. Toblli JE; Cao G; DeRosa G; Di Gennaro F; Forcada P Am J Hypertens; 2004 Feb; 17(2):172-80. PubMed ID: 14751661 [TBL] [Abstract][Full Text] [Related]
3. ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats. Toblli JE; DeRosa G; Cao G; Piorno P; Pagano P Kidney Int; 2004 Jun; 65(6):2343-59. PubMed ID: 15149348 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition reduces lipid deposits in myocardium and improves left ventricular function of obese zucker rats. Toblli JE; Cao G; Rivas C; DeRosa G; Domecq P Obesity (Silver Spring); 2006 Sep; 14(9):1586-95. PubMed ID: 17030970 [TBL] [Abstract][Full Text] [Related]
5. Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor beta1 in obese Zucker rats by perindopril. Toblli JE; Cao G; DeRosa G; Forcada P Heart; 2005 Jan; 91(1):80-6. PubMed ID: 15604340 [TBL] [Abstract][Full Text] [Related]
6. ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats. Toblli JE; Muñoz MC; Cao G; Mella J; Pereyra L; Mastai R Obesity (Silver Spring); 2008 Apr; 16(4):770-6. PubMed ID: 18239590 [TBL] [Abstract][Full Text] [Related]
7. Long-term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin-converting enzyme inhibitor/diuretic combination. Renaud IM; Chainey A; Belair MF; Mandet C; Michel O; Myara I; Chevalier J; Plante GE Fundam Clin Pharmacol; 2004 Aug; 18(4):437-47. PubMed ID: 15312150 [TBL] [Abstract][Full Text] [Related]
8. Effects of aerobic exercise training on cardiac renin-angiotensin system in an obese Zucker rat strain. Barretti DL; Magalhães Fde C; Fernandes T; do Carmo EC; Rosa KT; Irigoyen MC; Negrão CE; Oliveira EM PLoS One; 2012; 7(10):e46114. PubMed ID: 23077501 [TBL] [Abstract][Full Text] [Related]
9. Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension. Striffler JS; Bhathena SJ; Michaelis OE; Campbell JD; Hansen CT; Scalbert E; Thibault N; Velasquez MT Metabolism; 1998 Oct; 47(10):1199-204. PubMed ID: 9781621 [TBL] [Abstract][Full Text] [Related]
10. Very-low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage. Laurent S J Hypertens Suppl; 2003 Jun; 21(3):S11-8. PubMed ID: 12929470 [TBL] [Abstract][Full Text] [Related]
11. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials. Waeber B J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862 [TBL] [Abstract][Full Text] [Related]
12. Improved glucose homeostasis in male obese Zucker rats coincides with enhanced baroreflexes and activation of the nucleus tractus solitarius. Chaudhary P; Schreihofer AM Am J Physiol Regul Integr Comp Physiol; 2018 Dec; 315(6):R1195-R1209. PubMed ID: 30256679 [TBL] [Abstract][Full Text] [Related]
13. Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: haemodynamic, biological and structural effects. Richard V; Joannides R; Henry JP; Mulder P; Mace B; Guez D; Schiavi P; Thuillez C J Hypertens; 1996 Dec; 14(12):1447-54. PubMed ID: 8986928 [TBL] [Abstract][Full Text] [Related]
14. Baroreflex and somato-reflex control of blood pressure, heart rate and renal sympathetic nerve activity in the obese Zucker rat. Davis G Exp Physiol; 2011 Jul; 96(7):623-34. PubMed ID: 21527543 [TBL] [Abstract][Full Text] [Related]
15. Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor. Levy BI; Duriez M; Samuel JL Am J Hypertens; 2001 Jan; 14(1):7-13. PubMed ID: 11206683 [TBL] [Abstract][Full Text] [Related]
16. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats. Rakusan K; Cicutti N; Maurin A; Guez D; Schiavi P Microvasc Res; 2000 Mar; 59(2):243-54. PubMed ID: 10684730 [TBL] [Abstract][Full Text] [Related]
17. Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected]. Ghiadoni L Expert Opin Pharmacother; 2010 Jul; 11(10):1647-57. PubMed ID: 20518617 [TBL] [Abstract][Full Text] [Related]
18. Hypertension-independent microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome. Frisbee JC Microcirculation; 2005; 12(5):383-92. PubMed ID: 16020387 [TBL] [Abstract][Full Text] [Related]
19. Significance of exaggerated natriuresis after angiotensin AT1 receptor blockade or angiotensin- converting enzyme inhibition in obese Zucker rats. Tallam LS; Jandhyala BS Clin Exp Pharmacol Physiol; 2001; 28(5-6):433-40. PubMed ID: 11380518 [TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients. Chalmers J; Castaigne A; Morgan T; Chastang C J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]